Rigel to Present at the Jefferies Global Healthcare Conference in London
Rigel Pharmaceuticals (RIGL) will present a company overview at the Jefferies Global Healthcare Conference in London on November 17, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Rigel Pharmaceuticals (RIGL) will present a company overview at the Jefferies Global Healthcare Conference in London on November 17, 2026. President and CEO Raul Rodriguez will present at 12:00 p.m. GMT (7:00 a.m. ET). A live webcast and archived recording will be available through the Investor Relations section of www.rigel.com.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David Rosen
Argot Partners
646.461.6387
david.rosen@argotpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-jefferies-global-healthcare-conference-in-london-302934145.html
SOURCE Rigel Pharmaceuticals, Inc.